About EPIGEN BIOSCIENCES INC
Epigen Biosciences Inc is a biotechnology company focused on developing novel therapeutics for high unmet medical needs, targeting diseases such as diabetic kidney disease, NASH/MASH, IPF, Alzheimer's disease, ALS, Fragile X syndrome, and stroke.
Development of small-molecule selective LPA1 antagonists for diabetic kidney disease, NASH/MASH, and IPFCreation of sigma-1 receptor (S1R) ligands for Alzheimer's disease and ALSDiscovery of p70 S6 kinase inhibitors for Fragile X syndromeResearch on PAM-II-based therapies for stroke and TBI
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Defense | $861K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to EPIGEN BIOSCIENCES INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.